NasdaqGS - Delayed Quote USD

United Therapeutics Corporation (UTHR)

Compare
367.36 +3.03 (+0.83%)
At close: November 21 at 4:00 PM EST
367.50 +0.14 (+0.04%)
Pre-Market: 7:14 AM EST

Valuation Measures

Annual
Monthly
Currency in USD
Download
Current9/30/20246/30/20243/31/202412/31/20239/30/2023
Market Cap 16.40B 15.99B 14.13B 10.06B 10.33B 10.60B
Enterprise Value 13.47B 13.52B 12.03B 7.76B 8.26B 8.72B
Trailing P/E 16.14 16.47 15.08 11.60 12.13 12.80
Forward P/E 13.46 12.71 13.57 10.05 9.78 10.60
PEG Ratio (5yr expected) 1.58 1.46 -- 2.37 1.34 1.79
Price/Sales 6.51 6.74 6.34 4.91 4.94 5.28
Price/Book 2.69 2.81 2.65 1.70 1.81 1.96
Enterprise Value/Revenue 4.89 5.17 4.81 3.34 3.75 4.13
Enterprise Value/EBITDA 8.67 8.91 8.05 5.60 6.52 7.14
9/30/2023 - 6/17/1999

Upgrade to begin using 40 years of earnings data and get so much more.

Build financial models with decades of earnings stats, ratios, and valuation data — all exportable — to power your trade ideas.

Upgrade

Financial Highlights

Fiscal Year

Fiscal Year Ends 12/31/2023
Most Recent Quarter (mrq) 9/30/2024

Profitability

Profit Margin 40.31%
Operating Margin (ttm) 54.51%

Management Effectiveness

Return on Assets (ttm) 11.89%
Return on Equity (ttm) 18.81%

Income Statement

Revenue (ttm) 2.76B
Revenue Per Share (ttm) 60.24
Quarterly Revenue Growth (yoy) 22.90%
Gross Profit (ttm) --
EBITDA 1.41B
Net Income Avi to Common (ttm) 1.11B
Diluted EPS (ttm) 22.78
Quarterly Earnings Growth (yoy) 15.50%

Balance Sheet

Total Cash (mrq) 3.33B
Total Cash Per Share (mrq) 74.51
Total Debt (mrq) 400M
Total Debt/Equity (mrq) 6.56%
Current Ratio (mrq) 4.58
Book Value Per Share (mrq) 136.74

Cash Flow Statement

Operating Cash Flow (ttm) 1.14B
Levered Free Cash Flow (ttm) 710.09M

Trading Information

Stock Price History

Beta (5Y Monthly) 0.56
52 Week Range 3 58.94%
S&P 500 52-Week Change 3 30.47%
52 Week High 3 417.82
52 Week Low 3 208.62
50-Day Moving Average 3 364.39
200-Day Moving Average 3 301.70

Share Statistics

Avg Vol (3 month) 3 357.6k
Avg Vol (10 day) 3 355.41k
Shares Outstanding 5 44.64M
Implied Shares Outstanding 6 44.64M
Float 8 40.93M
% Held by Insiders 1 1.84%
% Held by Institutions 1 100.87%
Shares Short (10/31/2024) 4 2.3M
Short Ratio (10/31/2024) 4 7.51
Short % of Float (10/31/2024) 4 6.79%
Short % of Shares Outstanding (10/31/2024) 4 5.16%
Shares Short (prior month 9/30/2024) 4 2.24M

Dividends & Splits

Forward Annual Dividend Rate 4 --
Forward Annual Dividend Yield 4 --
Trailing Annual Dividend Rate 3 0.00
Trailing Annual Dividend Yield 3 0.00%
5 Year Average Dividend Yield 4 --
Payout Ratio 4 0.00%
Dividend Date 3 --
Ex-Dividend Date 4 --
Last Split Factor 2 2:1
Last Split Date 3 9/23/2009

Footnotes

  • 1 Data provided by Refinitiv.
  • 2 Data provided by EDGAR Online.
  • 3 Data derived from multiple sources or calculated by Yahoo Finance.
  • 4 Data provided by Morningstar, Inc.
  • 5 Shares outstanding is taken from the most recently filed quarterly or annual report and Market Cap is calculated using shares outstanding.
  • 6 Implied Shares Outstanding of common equity, assuming the conversion of all convertible subsidiary equity into common.
  • 7 EBITDA is calculated by S&P Global Market Intelligence using methodology that may differ from that used by a company in its reporting.
  • 8 A company's float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which may not be publicly traded.

Abbreviation Guide

  • mrq?=?Most Recent Quarter
  • ttm?=?Trailing Twelve Months
  • yoy?=?Year Over Year
  • lfy?=?Last Fiscal Year
  • fye?=?Fiscal Year Ending

Related Tickers